Electrocompetent Cells Market

by

Gene Delivery Is Fastest Growing Segment Fueling The Growth Of Electrocompetent Cells Market

The global Electrocompetent Cells Market is estimated to be valued at US$ 2.07 Bn in 2023 and is expected to exhibit a CAGR of 10.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Electrocompetent cells are used for efficient gene delivery by electroporation. They enable uptake of DNA into bacterial cells through making the cell membrane permeable to DNA by applying an external electric field. This provides advantages like greater transformation efficiencies, higher transformation rates, and successful transformation of plasmids of any size.

Market key trends:
One of the key trends in the electrocompetent cells market is the increasing adoption of electroporation for gene delivery applications. Electroporation facilitates rapid entry of nucleic acids into bacterial cells without the use of antibiotics or chemical transformation aids. This makes it a highly efficient and simple method for gene delivery. The use of electrocompetent cells enhances gene transformation rates and allows higher throughput of genetic manipulations. Their ease of use is driving increased preference among research labs for biomedical applications involving gene editing, gene therapy, and genetic engineering.
Segment Analysis
The Electrocompetent Cells Market Growth can be segmented by type into chemically competent cells and electrocompetent cells. Among these, the electrocompetent cells segment held the largest market share in 2023 and is expected to remain dominant over the forecast period. Electrocompetent cells have higher transformation efficiencies than chemically competent cells and are widely used for cloning and subcloning experiments involving plasmid DNA.

Key Takeaways
The global electrocompetent cells market is expected to witness high growth, exhibiting a CAGR of 10% over the forecast period, due to increasing adoption in proteomic research and nucleic acid studies.

Regional analysis
North America dominated the global electrocompetent cells market in 2023 and is expected to continue its dominance over the forecast period. This is attributed to the presence of major players and advanced research infrastructure in the region. Asia Pacific is expected to be the fastest growing market for electrocompetent cells owing to rising R&D investments and increasing government funding for life science research in countries such as China and India.

Key players
Key players operating in the electrocompetent cells market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Inc., QIAGEN N.V., Bio-Rad Laboratories, Inc., New England Biolabs, Inc., GenScript Biotech Corporation, Lucigen Corporation, Takara Bio Inc., Delphi Genetics S.A., IBA GmbH, Scarab Genomics LLC, Zymo Research Corporation, Bioline GmbH (Meridian Bioscience), Cell Applications, Inc. Thermo Fisher Scientific Inc. and Merck KGaA captured significant market shares in 2023.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it